DEPARTMENTS | DIRECTORY | ADVANCED SEARCH | SCHOOL HOME
School Home NYU School of Medicine

irb
 Today is Saturday, September 6th 2008
 
Guidance Documents
Decision Charts -
Human Subject Regulations Decision Charts
NYU SoM IRB Guidelines for Writing a Research Protocol
Guidance of Required Elements of a Protocol
Guidance on Determining Human Subjects Research
Guidance on Submitting a New Application
Guidance on Using an FDA Regulated Product
Guidance for the Investigator as a Sponsor
Guidance for Data Monitoring Plans
Guidance for Emergency Use of an IND
Guidance for Emergency Use of an IND-IDE
Guidelines for Research in Pregnant Women, Human Fetuses and Neonates
Guidance on Research with Prisoners
Guidelines for Involving Children in Research
Guidance for Cognitively Impaired
Guidance for Students and Employees in Research
Guidelines for Recruitment of Research Subjects
Guidelines for Advertisements for Research Subjects
Guidance on Genetic Research
Guidelines on Protocol Development for Genetic Research
Guidance on the Consent Process and Documentation
Guidelines of Requests for Waiver of Consent
Guidance on Assent of A Minor
Guidance for Non-English Speaking Subjects
Guidance on Verbal Consent
Guidance on Waiver of Parental Permission
Guidelines for Amending a Protocol
Guidance on Continuing Review and Final Closures
Essential Documents
Guidelines to Investigator Responsibilities
Letter for Sponsors - Reportable Events Policy
Guidance for Reportable Events and Reporting Unanticipated Problems
Reviews Preparatory to Research

Research Data Compilations

How many copies do I submit?
 

Guidance on Determining if Activities Meet Organizational Definition of Human Subjects Research

You can also download this page in PDF |MS Word format.

Under NYU SoM IRB policies and procedures an activity is human research if it is described in any one of the following:

HUMAN SUBJECT RESEARCH UNDER FDA REGULATION
Activities are human research under FDA regulations when they meet the FDA definition of “research” and involve a “subject” as defined in FDA regulations. Under FDA regulations activities are “research” when they involve:

  1. Use of a drug other than the use of an approved drug in the course of medical practice 
  2. Use of a medical device other than the use of an approved medical device in the course of medical practice (Food, Drug and Cosmetic Act §530(g)(3)(a)(i)) 
  3. Gather data that will be submitted to or held for inspection by FDA in support of a FDA marketing permit for a food, including a dietary supplement that bears a nutrient content claim or a health claim, an infant formula, a food or color additive, a drug for human use, a medical device for human use, a biological product for human use, or an electronic product. (21 CFR §50.1(a), or 21 CFR §56.101(a))

In the above criteria “approved” means “approved by the FDA for marketing.”

Under FDA regulations, individuals are considered “subjects” when they become a participant in research, either as a recipient of the test article or as a control. If the research involves a medical device, individuals are considered “subjects” when they participate in an investigation, either as an individual on whom or on whose specimen an investigational device is used or as a control.

The following activities also require IRB review under FDA Regulations: emergency use of an investigational drug, device, or biologic under 21 CFR 56.104(c) and 21 CFR 50.23 and humanitarian device use under 21 CFR 814.3(n) and 814.124.

HUMAN SUBJECT RESEARCH UNDER HHS REGULATIONS

Activities are human subject research under HHS regulations when they meet the HHS definition of “research” (§46.102(d)) and involve a “subject” as defined in DHHS regulations (§46.102(f)).

Under DHHS regulations activities are “research” when they are a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge (§46.102(d)).  

Under DHHS regulations “subjects” means a living individual about whom an investigator (whether professional or student) conducting research obtains (1) data through intervention or interaction with the individual, or (2) identifiable private information (§46.102(f)).
Intervention includes both physical procedures by which data are gathered (for example, venipuncture) and manipulations of the subject or the subject’s environment that are performed for research purposes (§46.102(f)).

Interaction includes communication or interpersonal contact between investigator and subject (§46.102(f)).

Private information includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place, and information which has been provided for specific purposes by an individual and which the individual can reasonably expect will not be made public (for example, a medical record). Private information must be individually identifiable (i.e., the identity of the subject is or may readily be ascertained by the investigator or associated with the information) in order for obtaining the information to constitute research involving human subjects (§46.102(f)).


 

IRB Resources
HRPP Accreditation Tutorial
IRB CITI Tutorials
Decision Charts -
Human Subject Regulations Decision Charts
IRB Newsletter
IRB Course Calendar
Policies and Procedures
HELP Downloading Forms
Lay Glossary
Useful Web Links
Sponsored Programs Administration (SPA)
Office of Clinical Trials (OCT)
Email a Suggestion or Comment to the IRB
Contact the IRB
GCRC Web Page
Instructions for Research Conducted at Bellevue
Printer-Friendly Version
Email this to a friend


Dept. Home | FAQs | IRB Forms | HIPAA Forms | Other Forms | Consent Templates | Info Sheets | Tool Kit | Schedule | Categories of Review | Policies | Glossary | Helpful Web Links | FWA | Contact